Gautam Patel Transfers Shares of Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Jan 03, 2024

SEC Form 4 · No Market Transaction

Gift

Transfer of shares as a gift.

Reporting Owner

Gautam Patel

Director

TXN 2024-01-01 · FILED 2024-01-03

Equity Position 374K sh 32,234,270 → 374,318

Equity Change -98.8% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128

Reporting Owner

Name	Relationship
Gautam Patel CIK 0001738054	Director

Gautam Patel at Amneal Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Amneal Pharmaceuticals Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Class A Common StockF1 F1	2024-01-01	J - Other	33,458,067 D		—	374,318	Direct
Class A Common StockF2	2024-01-01	G - Gift	1,598,115 A	$0.00	—	1,972,433	Direct

Footnotes (2)

F1: The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee. Show more
F2: The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc

GET /v1/forms/4/0000898432-24-000011 API docs